Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006617
Filing Date
2025-03-04
Accepted
2025-03-04 17:27:45
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03042025_100341.html 4  
1 form4-03042025_100341.xml 4 3277
  Complete submission text file 0001415889-25-006617.txt   4621
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 13543 WATER CREST DRIVE FISHERS IN 46038
Business Address
Kinard David S (Reporting) CIK: 0001752439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 25706670